Abstract

Respiratory failure in HIV-infected patients is a relatively common presentation to ICU. The debate on ICU treatment of HIV-infected patients goes on despite an overall decline in mortality amongst these patients since the AIDS epidemic. Many intensive care physicians feel that ICU treatment of critically ill HIV patients is likely to be futile. This is mainly due to the unfavourable outcome of HIV patients with Pneumocystis jirovecii pneumonia who need mechanical ventilation. However, the changing spectrum of respiratory illness in HIV-infected patients and improved outcome from critical illness remain under-recognised. Also, the awareness of certain factors that can affect their outcome remains low. As there are important ethical and practical implications for intensive care clinicians while making decisions to provide ICU support to HIV-infected patients, a review of literature was undertaken. It is notable that the respiratory illnesses that are not directly related to underlying HIV disease are now commonly encountered in the highly active antiretroviral therapy (HAART) era. The overall incidence of P. jirovecii as a cause of respiratory failure has declined since the AIDS epidemic and sepsis including bacterial pneumonia has emerged as a frequent cause of hospital and ICU admission amongst HIV patients. The improved overall outcome of HIV patients needing ICU admission is related to advancement in general ICU care, including adoption of improved ventilation strategies. An awareness of respiratory illnesses in HIV-infected patients along with an appropriate diagnostic and treatment strategy may obviate the need for invasive ventilation and improve outcome further. HIV-infected patients presenting with respiratory failure will benefit from early admission to critical care for treatment and support. There is evidence to suggest that continuing or starting HAART in critically ill HIV patients is beneficial and hence should be considered after multidisciplinary discussion. As a very high percentage (up to 40%) of HIV patients are not known to be HIV infected at the time of ICU admission, the clinicians should keep a low threshold for requesting HIV testing for patients with recurrent pneumonia.

Highlights

  • During the HIV epidemic in the early 1980s, critical illness in HIV infected patients was associated with poor prognosis with very high mortality and morbidity

  • The main aim of this review is to provide an overview of changing outcome and disease patterns in HIV patients presenting with respiratory failure

  • Respiratory failure is a relatively common presentation in HIV-infected patients, often requiring admission to critical care. Outcomes for such patients have significantly improved since the AIDS epidemic and currently is comparable to that of non-HIV patients

Read more

Summary

Introduction

During the HIV epidemic in the early 1980s, critical illness in HIV infected patients was associated with poor prognosis with very high mortality and morbidity. The reluctance to admit HIV-infected patients to ICU may be because studies persistently reported need for mechanical ventilation as the main predictor of mortality in these patients [2,5,8,15,16,23,30,31,33,35,37] This group of patients demonstrates significantly higher rates of developing ventilator-associated pneumonia compared to non-HIV patients needing mechanical ventilation [41]. Use of HAART in HIV patients admitted to ICU Clinical trials and meta-analysis have definitely shown that HAART improves survival and reduces AIDSrelated complications in patients with advanced disease even when they present with acute opportunistic infections [134,135]. Deferral of the initiation of HAART to the first 4 weeks of the continuation phase of TB therapy can reduce the risks of adverse effects of HAART without increasing the risk of death [17]

Conclusion
Findings
72. Bigby TD
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call